A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

Fiancé star Liz Woods has given a heartbreaking update about her health and love life with Jayson Zuniga after confirming she ...

A low prognostic nutritional index is associated with an increased risk for 90-day mortality and adverse postoperative ...

AstraZeneca and Daiichi Sankyo’s drug extended survival by 30% compared to a widely used regimen, further establishing its ...

Patients with newly diagnosed gastric or gastroesophageal junction (GEJ) cancer who received the PD-L1 inhibitor durvalumab ...